Permeability modulation of human intestinal Caco-2 cell monolayers by interferons

Area of Science:

• Cell biology
• Pharmacology
• Immunology

Background:

• The human intestinal Caco-2 cell line is a model for studying drug transport.
• P-glycoprotein (P-gp) is a key efflux transporter in the intestinal barrier.
• Interferons (IFNs) are cytokines with immunomodulatory functions that may affect cellular transport.

Purpose of the Study:

• To investigate the effects of IFN-beta and IFN-gamma on P-gp mediated drug efflux in Caco-2 cells.
• To determine if IFNs alter the permeability of the Caco-2 intestinal barrier.
• To elucidate the mechanism by which IFNs modulate Caco-2 cell monolayer transport.

Main Methods:

• Caco-2 cells grown on Transwell plates were pretreated with IFN-beta, IFN-gamma, or both.
• Transepithelial electrical resistance (TEER) was measured to assess barrier integrity.
• Vectorial transport and cellular uptake of rhodamine-123 (Rho-123) were evaluated.
• The effect of verapamil, a P-gp inhibitor, was assessed.

Main Results:

• IFN-gamma significantly reduced TEER, indicating decreased barrier integrity.
• IFN-gamma increased Rho-123 permeability in both directions, while IFN-beta had minimal effects.
• IFN treatments did not alter Rho-123 cellular uptake or verapamil-inhibited uptake, suggesting P-gp activity was unaffected.
• Combined IFN treatment yielded similar results to IFN-gamma alone.

Conclusions:

• IFNs modulate Caco-2 monolayer permeability primarily by affecting paracellular transport.
• These cytokines do not directly alter the efflux activity of P-glycoprotein in this model.
• Findings suggest IFNs may influence intestinal drug absorption through mechanisms other than P-gp modulation.